Enquiry Now
Loading...
| A04145 | Pages: NA | Aug 2021 | 3328 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Mri Compatible Iv Infusion Pumps Market
Request Now !Infusion pumps are the medical devices that deliver fluids in particular doses into the patients body. These are employed to inject fluids such as nutrients and medications. MRI compatible IV infusion pumps provides safe and accurate delivery of intravenous fluids during and after an MRI scan.
Rise in prevalence of life threatening diseases, high demand of MRI diagnostics, growth in geriatric population, and increase in hospitalization of patients drive the market. However, factors such as high cost of devices and lack of awareness about the procedure restrain the market growth. The development of advanced IV infusion pump systems and untapped markets provide numerous opportunities for the market growth.
MRI compatible IV infusion pumps market is segmented on the basis of product type, end user, and region. On the basis of product type, the market is bifurcated into pumps, and tubing & disposables. Pumps can be further sub-segmented into infusion and IV pumps. Infusion pumps can be segmented as, magnetic and non-magnetic pump system and IV pumps as peristal IV pumps, and piston driven pumps. Based on end user, the market is divided into hospitals, ambulatory surgical centers, and diagnostics & imaging centers. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in this market include B. Braun Melsungen AG, IRadimed Corporation, Arcomed AG, Fresenius SE & Co. KGaA, Becton, Dickinson and Company, Baxter International Inc., Medtronic Plc., Smiths Group plc, F. Hoffmann-La Roche AG, and Kimberly-Clark Health Care.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY PRODUCT TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PUMPS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Infusion Pumps
4.2.4.1. Market size and forecast
4.2.4.2. Magnetic Pumps
4.2.4.2.1. Market size and forecast
4.2.4.3. Non-Magnetic Pumps
4.2.4.3.1. Market size and forecast
4.2.5. IV Pumps
4.2.5.1. Market size and forecast
4.2.5.2. Peristal IV Pumps
4.2.5.2.1. Market size and forecast
4.2.5.3. Piston Driven Pumps
4.2.5.3.1. Market size and forecast
4.3. TUBING AND DISPOSABLES
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
CHAPTER 5 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY END USER
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. HOSPITALS
5.2.1. Market size and forecast
5.3. AMBULATORY SURGICAL CENTERS
5.3.1. Market size and forecast
5.4. DIAGNOSTICS AND IMAGING CENTERS
5.4.1. Market size and forecast
CHAPTER 6 MRI COMPATIBLE IV INFUSION PUMPS MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America MRI Compatible IV Infusion Pumps Market by Product Type
6.2.5. North America MRI Compatible IV Infusion Pumps Market by End User
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe MRI Compatible IV Infusion Pumps Market by Product Type
6.3.5. Europe MRI Compatible IV Infusion Pumps Market by End User
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific MRI Compatible IV Infusion Pumps Market by Product Type
6.4.5. Asia-Pacific MRI Compatible IV Infusion Pumps Market by End User
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast
6.5.4. LAMEA MRI Compatible IV Infusion Pumps Market by Product Type
6.5.5. LAMEA MRI Compatible IV Infusion Pumps Market by End User
CHAPTER 7 COMPANY PROFILES
7.1. B. BRAUN MELSUNGEN AG
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. IRADIMED CORPORATION
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. ARCOMED AG
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. FRESENIUS SE & CO. KGAA
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. BECTON, DICKINSON AND COMPANY
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. BAXTER INTERNATIONAL INC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. MEDTRONIC PLC.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. SMITHS GROUP PLC
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. F. HOFFMANN-LA ROCHE AG
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. KIMBERLY-CLARK HEALTH CARE
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
